Charles Dadswell
General Counsel chez ILLUMINA, INC.
Fortune : 3 M $ au 31/03/2024
Profil
Actuellement, Charles E. Dadswell est secrétaire, vice-président principal et responsable de la conformité chez Illumina, Inc. Au cours de sa carrière antérieure, M. Dadswell a été chef du contentieux de BioDelivery Sciences International, Inc, vice-président de la propriété intellectuelle aux États-Unis chez GlaxoSmithKline, Inc, directeur chez Glaxo Wellcome, Inc et vice-président et chef du contentieux pour l'Amérique du Nord et l'Amérique latine chez bioMérieux, Inc. Charles E. Dadswell a obtenu un diplôme de premier cycle de l'université d'État de Ferris (Michigan), un diplôme d'études supérieures de la Thomas M. Cooley Law School et un diplôme d'études supérieures de la George Washington University Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ILLUMINA, INC.
0,01% | 05/03/2024 | 22 298 ( 0,01% ) | 3 M $ | 31/03/2024 |
Postes actifs de Charles Dadswell
| Sociétés | Poste | Début |
|---|---|---|
| ILLUMINA, INC. | General Counsel | 22/04/2013 |
Anciens postes connus de Charles Dadswell
| Sociétés | Poste | Fin |
|---|---|---|
bioMérieux, Inc.
 bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | General Counsel | 01/04/2013 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | General Counsel | 01/01/2010 |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Formation de Charles Dadswell
| Ferris State University (Michigan) | Undergraduate Degree |
| The Thomas M. Cooley Law School | Graduate Degree |
| George Washington University Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
bioMérieux, Inc.
bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
